The efficacy and safety of adding on or switching to peginterferon α‐2b in HBeAg‐positive chronic hepatitis B patients with long‐term entecavir treatment: a multicentre randomised controlled trial-Reference-Cited by-同舟云学术

The efficacy and safety of adding on or switching to peginterferon α‐2b in HBeAg‐positive chronic hepatitis B patients with long‐term entecavir treatment: a multicentre randomised controlled trial

Published:2022-09-20 Issue:9 Volume:56 Page:1394-1407
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Hu Qiankun¹,Qi Xun¹,Yu Yiqi²,Gao Yueqiu³,Zhang Xinxin⁴^ORCID,Wang Qianqian¹,Zhang Xueyun²,Zhuo Yunhui³,Li Jing⁴,Zhang Jiming²^ORCID,Chen Liang¹,Huang Yuxian¹²^ORCID

Affiliation:

1. Department of Liver Diseases, Shanghai Public Health Clinical Center Fudan University Shanghai China

2. Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital Fudan University Shanghai China

3. Department of Liver Diseases Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China

4. Department of Infectious Diseases, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17222

Reference42 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

2. Chronic hepatitis B virus infection

3. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

5. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment;Journal of Nanobiotechnology;2024-06-05

2. CXCL13 variant predicts pegylated‐interferon α treatment response in HBeAg‐positive chronic hepatitis B patients;Journal of Medical Virology;2023-07